On this page

Anal Cancer Screening Guidelines for PLHIV

Last updated: November 2024

Appendix 1. Grading of recommendations

ASHM recommendations are rated according to the criteria used by the US National Institutes of Health Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. The letters A, B, or C signify the strength of the recommendation for or against a preventive or therapeutic measure, and the Roman numerals I, II, or III indicate the quality of the evidence supporting the recommendation. In cases where there are no data for the prevention or treatment of an Opportunistic Infection based on studies conducted in people with HIV, but there are data derived from studies in people without HIV that could plausibly guide management of patients with HIV, the recommendation is rated II or III but is assigned A, B, or C depending on the strength of the recommendation.

Table. Rating System for Prevention and Treatment Recommendations18
Strength of RecommendationQuality of Evidence for the Recommendation
A: Strong recommendation for the statement.I: One or more randomized trials with clinical outcomes and/or validated laboratory endpoints.
B: Moderate recommendation for the statement.II: One or more well-designed, non-randomized trials or observational cohort studies with long-term clinical outcomes.
C: Weak recommendation for the statement.III: Expert opinion.

Acknowledgement of Country

ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.

ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2024 ASHM

Scroll to Top